Biotech policy, regulations & bioethics form the foundational framework that ensures responsible innovation in biotechnology. As advances in genetic editing, synthetic biology, and personalized medicine accelerate, regulatory agencies and global policymakers face the challenge of balancing innovation with public safety and ethical integrity. This field encompasses the formulation of guidelines governing clinical trials, intellectual property, environmental release, and cross-border biotech trade. Bioethics plays a critical role in addressing concerns surrounding genome editing, data privacy, consent in biobanking, and equity in access to biotech products. Biotech policy, regulations & bioethics ensure transparency, accountability, and societal trust while facilitating global collaboration. A well-regulated landscape not only protects public interests but also accelerates adoption of life-enhancing technologies in healthcare, agriculture, and the environment.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States